Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kinetics

被引：0
|
作者：
Voget, Rabea [1 ]
Breidenbach, Julian [1 ]
Claff, Tobias [1 ]
Hingst, Alexandra [1 ]
Sylvester, Katharina [1 ]
Steinebach, Christian [1 ]
Vu, Lan Phuong [1 ]
Weisse, Renato H. [2 ]
Bartz, Ulrike [3 ]
Straeter, Norbert [2 ]
Mueller, Christa E. [1 ]
Guetschow, Michael [1 ]
机构：
[1] Univ Bonn, Pharmaceut Inst, Pharmaceut & Med Chem, D-53121 Bonn, Germany
[2] Univ Leipzig, Inst Bioanalyt Chem, Ctr Biotechnol & Biomed, D-04103 Leipzig, Germany
[3] Univ Appl Sci Bonn Rhein Sieg, Dept Nat Sci, D-53359 Rheinbach, Germany
来源：
ACTA PHARMACEUTICA SINICA B | 2024年 / 14卷 / 05期
关键词：
COVID-19; SARS-CoV-2; Main protease; Peptide nitriles; Fluorogenic substrates; Active-site titration; X-ray crystallography; Inner filter effect; SUBSTRATE-INHIBITION; FLUORESCENCE;
D O I：
10.1016/j.apsb.2024.03.0012211-3835
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
A titrant for the SARS-CoV-2 main protease (M-pro) was developed that enables, for the first time, the exact determination of the concentration of the enzymatically active M-pro by active-site titration. The covalent binding mode of the tetrapeptidic titrant was elucidated by the determination of the crystal structure of the enzyme-titrant complex. Four fluorogenic substrates of M-pro, including a prototypical, internally quenched Dabcyl-EDANS peptide, were compared in terms of solubility under typical assay conditions. By exploiting the new titrant, key kinetic parameters for the M-pro-catalyzed cleavage of these substrates were determined.
引用
收藏
页码：2349 / 2357
页数：9
相关论文
共 50 条
  • [41] Exploring diverse reactive warheads for the design of SARS-CoV-2 main protease inhibitors
    Tan, Bin
    Sacco, Michael
    Tan, Haozhou
    Li, Kan
    Joyce, Ryan
    Zhang, Xiujun
    Chen, Yu
    Wang, Jun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 259
  • [42] A Quick Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors**
    Yang, Kai S.
    Ma, Xinyu R.
    Ma, Yuying
    Alugubelli, Yugendar R.
    Scott, Danielle A.
    Vatansever, Erol C.
    Drelich, Aleksandra K.
    Sankaran, Banumathi
    Geng, Zhi Z.
    Blankenship, Lauren R.
    Ward, Hannah E.
    Sheng, Yan J.
    Hsu, Jason C.
    Kratch, Kaci C.
    Zhao, Baoyu
    Hayatshahi, Hamed S.
    Liu, Jin
    Li, Pingwei
    Fierke, Carol A.
    Tseng, Chien-Te K.
    Xu, Shiqing
    Liu, Wenshe Ray
    CHEMMEDCHEM, 2021, 16 (06) : 942 - 948
  • [43] Malleability of the SARS-CoV-2 3CL Mpro Active-Site Cavity Facilitates Binding of Clinical Antivirals
    Kneller, Daniel W.
    Galanie, Stephanie
    Phillips, Gwyndalyn
    O'Neill, Hugh M.
    Coates, Leighton
    Kovalevsky, Andrey
    STRUCTURE, 2020, 28 (12) : 1313 - +
  • [44] Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2
    Abel, Renata
    Ramos, Maria Paredes
    Chen, Qiaofeng
    Perez-Sanchez, Horacio
    Coluzzi, Flaminia
    Rocco, Monica
    Marchetti, Paolo
    Mura, Cameron
    Simmaco, Maurizio
    Bourne, Philip E.
    Preissner, Robert
    Banerjee, Priyanka
    FRONTIERS IN CHEMISTRY, 2020, 8
  • [45] A novel method for synthesizing authentic SARS-CoV-2 main protease
    Zhao, Cheng
    Rong, Yi
    Shi, Shuyuan
    Gao, Wen-chao
    Zhang, Chaofeng
    PROTEIN EXPRESSION AND PURIFICATION, 2024, 222
  • [46] Fragment Based Drug Discovery of SARS-CoV-2 Main Protease
    Song, W.
    Li, S.
    Chan, A. W. E.
    Coker, A.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2021, 77 : C705 - C705
  • [47] The temperature-dependent conformational ensemble of SARS-CoV-2 main protease (Mpro)
    Ebrahim, Ali
    Riley, Blake T.
    Kumaran, Desigan
    Andi, Babak
    Fuchs, Martin R.
    McSweeney, Sean
    Keedy, Daniel A.
    IUCRJ, 2022, 9 : 682 - 694
  • [48] SARS-CoV-2 main protease inhibitors: What is moving in the field of peptides and peptidomimetics?
    Algar-Lizana, Sergio
    Angeles Bonache, Maria
    Gonzalez-Muniz, Rosario
    JOURNAL OF PEPTIDE SCIENCE, 2023, 29 (05)
  • [49] Antiviral peptides inhibiting the main protease of SARS-CoV-2 investigated by computational screening and in vitro protease assay
    Stewart, James
    Shawon, Jakaria
    Ali, Md Ackas
    Williams, Blaise
    Shahinuzzaman, A. D. A.
    Rupa, Sharmin Akther
    Al-Adhami, Taha
    Jia, Ruoqing
    Bourque, Cole
    Faddis, Ryan
    Stone, Kaylee
    Sufian, Md Abu
    Islam, Rajib
    McShan, Andrew C.
    Rahman, Khondaker Miraz
    Halim, Mohammad A.
    JOURNAL OF PEPTIDE SCIENCE, 2024, 30 (04)
  • [50] Proteolytic cleavage and inactivation of the TRMT1 tRNA modification enzyme by SARS-CoV-2 main protease
    Zhang, Kejia
    Eldin, Patrick
    Ciesla, Jessica H.
    Briant, Laurence
    Lentini, Jenna M.
    Ramos, Jillian
    Cobb, Justin
    Munger, Joshua
    Fu, Dragony
    ELIFE, 2024, 12
12345